Skip to main navigation Skip to search Skip to main content

hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells

  • Jennifer Pérez-Boza
  • , Amandine Boeckx
  • , Michele Lion
  • , Franck Dequiedt
  • , Ingrid Struman
  • University of Liege

Research output: Contribution to journalArticleAcademicpeer-review

35 Downloads (Pure)

Abstract

The chemotherapeutic drug epirubicin increases the exosomal export of miR-503 in endothelial cells. To understand the mechanisms behind this process, we transfected endothelial cells with miR-503 carrying a biotin tag. Then, we pulled-down the proteins interacting with miR-503 and studied their role in microRNA exosomal export. A total of four different binding partners were identified by mass spectrometry and validated by western blotting and negative controls, among them ANXA2 and hnRNPA2B1. Using knock-down systems combined with pull-down analysis, we determined that epirubicin mediates the export of miR-503 by disrupting the interaction between hnRNPA2B1 and miR-503. Then, both ANXA2 and miR-503 are sorted into exosomes while hnRNPA2B1 is relocated into the nucleus. The combination of these processes culminates in the increased export of miR-503. These results suggest, for the first time, that RNA-binding proteins can negatively regulate the exosomal sorting of microRNAs.
Original languageEnglish
Pages (from-to)4413-4428
Number of pages16
JournalCellular and molecular life sciences
Volume77
Issue number21
DOIs
Publication statusPublished - 1 Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • EVs
  • Exosomal export
  • Exosomes
  • MicroRNAs
  • RNA-binding proteins

Fingerprint

Dive into the research topics of 'hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells'. Together they form a unique fingerprint.

Cite this